The field of diagnosing lung cancer has seen tremendous transformations, thanks to the introduction of technology that has made the diagnosis and treatment of lung cancer simpler. This is because the main challenge in lung cancer diagnosis is that it is detected at its advanced stage.
For a deeper market perspective, explore the lung cancer market analysis.
Liquid Biopsy: Enabling Non-Invasive and Real-Time Diagnostics
Liquid Biopsy has become one of the latest revolutionary inventions used for the diagnosis of lung cancer. Conventional methods include the use of invasive techniques as well as repeat testing; however, liquid biopsy enables the possibility of detecting cancer using blood tests via ctDNA, CTCs, and more.
The latest advances in technology have enabled the use of liquid biopsy from simple biomarker tests to multiple omics, incorporating the use of genomic, epigenomic, and fragmentomic tests. This enables the improved diagnosis of cancer at an earlier stage.
For instance, a recently conducted study in 2023 showed that a liquid biopsy test, aided by artificial intelligence, had the ability to detect early-stage lung cancer with 95% sensitivity.
(Source: exai.bio)
Artificial Intelligence and Radiomics Enhancing Diagnostic Accuracy
There are currently many types of radiology tools developed using artificial intelligence (AI), which are being integrated into imaging and diagnostic workflows, providing much improved accuracy and efficiency for the early detection of lung cancer. These radiology tools utilize AI algorithms to analyze computed tomograms (CTs) and positron emission tomography (PET) images in order to recognize small pulmonary nodules that may be missed through human interpretation alone.
With the improved performance of AI models, in terms of diagnostic accuracy, AI systems are now able to achieve higher levels of accuracy than traditional methods for identifying early-stage tumors, as well as outperforming radiologists.
Radiomics is an area of emerging research that is augmenting AI diagnostic capabilities through quantitative extraction of features from imaging data. When AI is combined with Radiomics techniques, the resulting characterization of tumors becomes more precise and further differentiates between benign and malignant pulmonary nodules.
Integration of Multimodal Diagnostics
One of the main trends that will drive innovative advances in how lung cancer is diagnosed in the future is the creation of a single diagnostic model that includes many diverse sources of data. Emerging methods of combining many forms of data, including image data, biomarker data, and patient history data, create a comprehensive picture of the patient's lung cancer.
Combining CT image data with liquid biopsy data through AI models has resulted in substantially higher classification accuracy for lung nodules and the ability to predict the likelihood of disease progression. The more types of data you incorporate into the diagnostic process for lung cancer, the more confidence you will have in providing an accurate diagnosis, ultimately resulting in less uncertainty for your patients.
Robotics and Advanced Biopsy Techniques
The development of non-invasive methods will aid in increasing the early detection of lung cancer. Robotic devices used in bronchoscopy and biopsy have enabled physicians to target difficult lung nodules.
Pilot studies conducted have revealed that with the use of robotic biopsy technology, there is an increase in the accuracy of tissue sampling, which reduces the number of repeat procedures.
Biomarker Discovery and Multi-Cancer Early Detection (MCED)
Biomarker-based technology is now providing novel avenues for testing the presence of lung cancer. New biomarkers are being discovered, including RNA profiles, DNA methylation levels, and protein-based biomarkers, which allow the early diagnosis of cancer.
Multi-cancer early detection (MCED), a type of test that uses biomarkers in the bloodstream for early detection of various forms of cancer, is increasingly popular. This test takes advantage of state-of-the-art sequencing and artificial intelligence technologies.
Conclusion
Advancements in technology have helped in detecting lung cancer through early diagnosis of lung cancer, increased accuracy, and individualized treatments. The following technologies are some examples of how the problems facing early lung cancer detection can be solved.
Through these advancements in technology and their incorporation into medical procedures, there is bound to be an increased shift towards early diagnosis of lung cancer.
Contact Us